Evidence map›Paper›PMID 39374430›Full record

ReviewAnnual review of pathology2025

Cysteinyl Leukotrienes in Allergic Inflammation.

Minkyu Lee, Joshua A Boyce, Nora A Barrett

Abstract readReview
In one paragraph

Review in Annual review of pathology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Review
  2. Observational
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. [Pathological roles of lipid metabolism disorders in asthma and related intervention strategies].Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2026
    Review
  13. Article
  14. IL-33 Elicits LTCEuropean journal of immunology · 2026
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Minkyu LeeDepartment of Medicine, Harvard Medical School, Boston, Massachusetts, USA.
Joshua A BoyceDepartment of Medicine, Harvard Medical School, Boston, Massachusetts, USA.
Nora A BarrettDepartment of Medicine, Harvard Medical School, Boston, Massachusetts, USA.

Funding

Therapeutic Control of Aspirin-Exacerbated Respiratory DiseaseU19AI095219 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI Nora Amanda Barrett · 2011 to 2026
$29.1M
IMMUNOLOGIC BASIS OF RESISTANCE AND HYPERSENSITIVITYT32AI007306 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI Nora Amanda Barrett, Joshua A Boyce · 1985 to 2026
$12.2M
Type 2 Inflammation and Remodeling Elicited Through an LTE4/OXGR1-dependent pathwayR01AI134989 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI Nora Amanda Barrett · 2019 to 2026
$5.1M
NIAID NIH HHS R01 AI134989NIAID NIH HHS T32 AI007306NIAID NIH HHS U19 AI095219
6 · The paper itself

Abstract

The cysteinyl leukotrienes (CysLTs), LTC

Indexed as

CysteineHypersensitivityInflammationLeukotrienesReceptors, LeukotrieneAnimalsAsthmaHumansCysteinecysteinyl-leukotrieneleukotriene D4 receptorLeukotrienesReceptors, Leukotrieneairway remodelingallergic inflammationaspirin-exacerbated respiratory diseaseasthmacysteinyl leukotriene

Identifiers

PMID39374430
PMCPMC11759657

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.